BeStock  
Stocks › Biotechnology › DSGN

Design Therapeutics DSGN

US equityMarket cap rank #3510Biotechnology
$9.02 −$0.30 (-3.22%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $9.02 0.00%
Open$9.33
Prev close$9.32
Day range$8.96 – $9.57
Volume281.9K
Market cap$577.61M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts3
Average target$21.67+140.2% vs. price
  • Buy 100%
Low $19.00Now $9.02Avg $21.67High $26.00

Recent rating changes

The last 20 actions on file set price targets from $14.00 to $26.00, averaging $19.05.

DateFirmRatingTarget
5 Nov 2026 Piper Sandler BUY $20.00
5 Nov 2026 RBC Capital BUY $19.00
12 Oct 2026 Wells Fargo BUY $26.00
2 Oct 2026 Wells Fargo BUY $26.00
4 Aug 2026 Craig-Hallum BUY $22.00
3 Aug 2026 RBC Capital BUY $20.00
15 Jun 2026 Oppenheimer BUY $21.00
27 May 2026 Piper Sandler BUY $20.00
19 May 2026 Craig-Hallum BUY $22.00
18 May 2026 RBC Capital BUY $20.00
4 May 2026 Oppenheimer BUY $21.00
29 Apr 2026 Craig-Hallum BUY $15.00
29 Apr 2026 Piper Sandler BUY $20.00
28 Apr 2026 RBC Capital BUY $14.00
15 Mar 2026 Jefferies BUY $15.00
10 Mar 2026 Craig-Hallum BUY $15.00
10 Mar 2026 Oppenheimer BUY $18.00
7 Jan 2026 Oppenheimer BUY $18.00
3 Dec 2025 Craig-Hallum BUY $15.00
3 Dec 2025 Leerink Partners BUY $14.00

Discussion

No comments yet — be the first to weigh in on DSGN.

Sign in to join the discussion.

Scroll to Top